EUCTR2006-006480-23-GB进行中（未招募）1 期
Autologous Bone Marrow-Derived Cells for Cardioprotection During Heart Surgery - Bone Marrow Cells & Cardioprotection
niversity Hospitals of Leicester0 个研究点目标入组 44 人开始时间: 2007年8月13日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Triple vessel coronary artery disease with or without significant disease of the left main stem with indication of elective surgical revascularization
- •Left ventricular ejection fraction greater than 40%
- •Age 20-80 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •In addition to not being compliant to the inclusion criteria, the following criteria will be sufficient to exclude patients from entering the study:
- •Cardiogenic shock (need for inotropic drugs, intra-aortic balloon pump)
- •Previous CABG
- •PCI in the previous 3 months
- •History of neoplastic disease
- •History of bleeding disorder
- •Chronic inflammatory disease
- •Active infection
- •Renal impairment (creatinine >180mmol/l)
- •Liver dysfunction (GOT >2xULN or INR >1.5)
- •Chronic treatment with oral antibiotic agents
研究者
相似试验
未知
不适用
Autologous bone marrow-derived cells for cardioprotection during heart surgeryIschaemic heart diseaseCirculatory SystemISRCTN22639386niversity Hospitals of Leicester NHS Trust (UK)44
进行中（未招募）
1 期
Bone marrow stem cell transplantation after acute spinal cord injuryCTRI/2014/01/004316Indian Council of Medical Research21
已完成
不适用
Autologous bone marrow cells in patients with critical limb ischemiaISRCTN16096154ational Institute of Heart and Vascular Diseases62
已完成
3 期
Bone Marrow Derived Mononuclear Cells For Myocardial RegenerationLeft Ventricular DysfunctionNCT00938847Asklepios proresearch20
已完成
2 期
Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)Dilated CardiomyopathyNCT00765518Vericel Corporation40